Davenport & Co’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,350
Closed -$221K 689
2019
Q4
$221K Buy
6,350
+200
+3% +$6.76K ﹤0.01% 655
2019
Q3
$211K Hold
6,150
﹤0.01% 636
2019
Q2
$211K Sell
6,150
-1,900
-24% -$64K ﹤0.01% 636
2019
Q1
$270K Sell
8,050
-1,000
-11% -$31.5K ﹤0.01% 562
2018
Q4
$250K Sell
9,050
-23,288
-72% -$722K ﹤0.01% 553
2018
Q3
$1.24M Buy
32,338
+1,812
+6% +$66.7K 0.01% 291
2018
Q2
$1.07M Sell
30,526
-9,770
-24% -$341K 0.01% 307
2018
Q1
$1.34M Buy
40,296
+8,161
+25% +$278K 0.02% 274
2017
Q4
$1.07M Buy
+32,135
New +$1.07M 0.01% 301

Other funds holding FFTY

Davenport & Co's FFTY Position: Q1 2020 in Review

Davenport & Co sold out of CapForce IBD 50 ETF (FFTY) in Q1 2020, closing a stake of 6,350 shares — an estimated $221K sold.

Davenport & Co first reported a position in FFTY in Q4 2017 and held it in 9 quarters. The position peaked at $1.34M in Q1 2018. 67 funds tracked by Wall St. Rank hold FFTY as of Q1 2020.

  • Davenport & Co reported no remaining CapForce IBD 50 ETF position as of Q1 2020 after selling out during the quarter.
  • Davenport & Co sold 6,350 CapForce IBD 50 ETF shares in Q1 2020, an estimated $221K.
  • Davenport & Co first reported a position in CapForce IBD 50 ETF in Q4 2017 and held it in 9 quarters.
  • Davenport & Co's CapForce IBD 50 ETF position peaked at $1.34M in Q1 2018.
  • 67 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2020.

Based on Davenport & Co's 13F filing for Q1 2020, filed 5 May 2020.